Healthy mineA technology-supported member participation and reward company focused on empowering members to take the right actions to improve their health, has announced a partnership with medical technology company ReferWell, which promotes effective care transitions in the last mile.
This partnership will enhance HealthMine’s member-oriented application to include seamless in-app appointment scheduling, close the most critical gaps in care, and reward members for health actions. Click here Read the full announcement.
Encelin, A personalized regenerative medicine biotechnology company that develops new cell-based methods to provide continuous treatment through a single implant. Last week, it announced the completion of $5.9 million in seed financing. Khosla Ventures and SV Latam Capital co-led this round of financing, and Sandhill Angels and Y Combinator participated in the round.
The new funds will be used to advance the development of its technology platform and projects in hypoglycemia and hypocalcemia. It will also be used to build laboratories and expand the team. Encellin will also expand to areas with ready-made renewable battery resources and engineered cells to encapsulate any cell cargo in its proprietary platform products.
Encellin manufactures implantable cell bags to treat chronic diseases. This technology combines new cell encapsulation technology with functional cell therapy to treat chronic diseases, starting with endocrine disorders. Encellin’s main program focuses on hypoglycemia, the highest unmet medical need in type 1 diabetes and hypocalcemia, affecting one-third of dialysis patients.
Dr. Crystal Nyitray, CEO and co-founder of Encellin, said: “This round of seed financing led by leading investors allows us to advance the development of our cell encapsulation devices in a variety of indications starting with chronic endocrine diseases.” Our team combines advanced technologies in the fields of nanotechnology and bioengineering to develop our proprietary Encellin platform, which uses known biocompatible materials to make nanoporous soft bags to support cell functions. We look forward to advancing We focus on the pipeline of endocrine diseases to use the power of cells to provide continuous treatment for patients with a single implant.”
To read more, Click here.
Karum Health Pallav Sharda has been appointed as its chief platform officer to lead the development of the company’s technology platform as they expand the supplier base and procedures for self-insurance employers. Sharda brings a unique combination of data science, product management, and clinical expertise to Carrum Health. Carrum Health is the first digital health company to connect employers and employees with a center of excellence (COE) through a technology-driven platform. Provide higher quality and more cost-effective surgical care.
Sach Jain, CEO and founder of Carrum Health, said: “It’s time to change the way people experience healthcare. I’m very happy to welcome Pallav’s leaders to help drive the development of our technology platform.” “Through our platform, we Almost every step of the surgical process is virtualized through the patient application, while radically simplifying the process for employers to adopt the COE plan.”
Before joining Carrum Health, Sharda not only worked on healthcare projects at Google’s parent company Alphabet’s R&D department X, but also served as the head of global healthcare and life sciences for Google Cloud. He teaches graduate-level medical informatics courses at Northwestern University. He has also served as Senior Director of Analysis at Kaiser Permanente and Director of HIE Product Management at UnitedHealth Group.
As a well-trained doctor, Sharda received a master’s degree in bioinformatics from Columbia University and worked in health IT product and engineering management for GE Healthcare early in his career. In addition, he served as Omnicell’s director of interoperability and partnerships, and co-founded Dovetail Care Inc., a health IT startup company.
Hydrogen health, A sort of Anthem and K Health joint venture With the support of Blackstone, Brad Kirkpatrick, Anthem’s former chief customer officer, was appointed chief commercial officer. The goal of the joint venture is to simplify access to primary care, including chronic, acute and preventive care.
His profile includes expanding existing partnerships, increasing employers and insurance partners, and collaborating to develop solutions to advance the value of employers and health plans.
“Primary care is the cornerstone of improving health and medical care costs, but 30-50% of the self-insured employer population does not have a primary care relationship. Employers want to provide employees with better, digital-first access,” Kirkpatrick said. “Adopting a new healthcare model is a top priority for companies, and Hydrogen has a unique advantage in providing the best technology, medical talent and expertise to introduce much-needed changes.”
Prior to joining Hydrogen, Kirkpatrick served as the Chief Customer Officer of WebMD.
To read more, Click here.
Wobo Health, A health technology company that develops digital therapies for mental health, hired King Goodwin as vice president of user experience. Before joining Woebert Health, Goodwin served as a consultant for Medtronic, Best Buy and Boeing. She has also held senior positions at PatientsLikeMe and strategy and design company Cooper.
Hiring follow the company’s $90 million in Series B financing last month, It said it will accelerate the development of its platform and technology, advance its leading digital therapy candidates, and expand its team and go-to-market activities. woebot also received Breakthrough device name Because it is a digital therapy designed to treat postpartum depression.
To read more, Click here.
picture: Aquindo, Getty Images
